Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial

NCT04647461 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma
Ocular Hypertensive

Interventions

DRUG: Brimonidine Tartrate 1.5mg
DRUG: Brimonidine Tartrate 1.5mg

Sponsor

CHA University

Collaborators

[object Object]